TOLERAGEN

TOLERAGEN is developing an mRNA-based technology that prevents the rejection of donor skin in patients with severe burns. This makes donor skin an effective and safe skin substitute that supports healing and significantly improves treatment options.
The company offers skin banks and donor skin distributors mRNA lipid nanoparticles that pass on the pretreated, immunomodulated skin to clinics.